Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters








Database
Language
Publication year range
1.
Int Immunopharmacol ; 83: 106430, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32279043

ABSTRACT

Ribonuclease (RNase) reportedly exerts organ-protective effects in several pathological conditions, including ischemia reperfusion (I/R), but whether it can exhibit protective effect on intestinal I/R injury and potential mechanisms remain unknown. The present study was aimed to evaluate the effects of RNase on intestinal I/R injury and explore the underlying mechanisms. Thirty-two wild-type C57BL/6J adult male mice were evenly divided into a sham group, a sham + RNase group, an I/R group and an I/R + RNase group. Intestinal I/R was produced by clamping the superior mesenteric artery for 1 h followed by reperfusion for 2 h. All mice were treated with 3 doses of RNase or the same dosage of normal saline at different points. It was found that intestinal I/R caused significant intestinal injury and an increase in levels of extracellular RNAs (exRNAs). Treatment with RNase significantly reduced the inflammatory cytokine production, inhibited intestinal apoptosis and down-regulated the expression of toll like receptor 3 in intestinal tissues. In conclusion, increased exRNAs may contribute to intestinal I/R injury in adult mice, and RNase treatment during perioperative window is effective for attenuating intestinal I/R injury.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Intestinal Diseases/drug therapy , Intestines/drug effects , Intestines/injuries , Reperfusion Injury/drug therapy , Ribonucleases/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Apoptosis/drug effects , Cytokines/drug effects , Cytokines/metabolism , Disease Models, Animal , Inflammation/drug therapy , Inflammation/metabolism , Intestinal Diseases/etiology , Intestinal Diseases/metabolism , Intestines/blood supply , Intestines/pathology , Male , Mice , Mice, Inbred C57BL , NF-KappaB Inhibitor alpha/drug effects , NF-KappaB Inhibitor alpha/metabolism , NF-kappa B/drug effects , NF-kappa B/metabolism , RNA/metabolism , Reperfusion Injury/complications , Ribonucleases/therapeutic use , Survival Rate , Toll-Like Receptor 3/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL